Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127335971 | 12733597 | 1 | I | 20110427 | 20151009 | 20160912 | 20160912 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK020095 | GLENMARK | 0.00 | Y | 0.00000 | 20160912 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127335971 | 12733597 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, TID | 19150367 | 77662 | 600 | MG | TABLET | TID | |||||
127335971 | 12733597 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, BID | 19150367 | 77662 | 600 | MG | TABLET | BID | |||||
127335971 | 12733597 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, TID (ONE TABLET IN MORNING AND TWO TABLETS BEFORE BEDTIME) | 77662 | 600 | MG | TABLET | TID | ||||||
127335971 | 12733597 | 4 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | UNK, QD | 0 | TABLET | |||||||||
127335971 | 12733597 | 5 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | UNK, QID | 0 | TABLET | QID | ||||||||
127335971 | 12733597 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | UNK, QD | 0 | TABLET | |||||||||
127335971 | 12733597 | 7 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | UNK, QD | 0 | TABLET | |||||||||
127335971 | 12733597 | 8 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | UNK, QD | 0 | TABLET | |||||||||
127335971 | 12733597 | 9 | C | OXYCODONE | OXYCODONE | 1 | Oral | UNK, BID | 0 | TABLET | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127335971 | 12733597 | 1 | Diabetic neuropathy |
127335971 | 12733597 | 4 | Type 2 diabetes mellitus |
127335971 | 12733597 | 5 | Type 2 diabetes mellitus |
127335971 | 12733597 | 6 | Hypertension |
127335971 | 12733597 | 7 | Anticoagulant therapy |
127335971 | 12733597 | 8 | Product used for unknown indication |
127335971 | 12733597 | 9 | Pain |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127335971 | 12733597 | Drug ineffective | |
127335971 | 12733597 | Off label use | |
127335971 | 12733597 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127335971 | 12733597 | 1 | 20110427 | 0 | ||
127335971 | 12733597 | 2 | 2012 | 0 | ||
127335971 | 12733597 | 4 | 20150924 | 0 |